4 free views remaining today
spastic ataxia 8
Description
Spastic ataxia 8, also known as SCA8, is a rare genetic disorder that affects the nervous system. It is characterized by early-onset hypotonia (low muscle tone) progressing to a pyramidal syndrome with ataxia, spasticity, hyperreflexia, weakness, and loss of ambulation [1][4].
The symptoms of SCA8 typically begin in childhood, often within the first 5 years of life. The first signs and symptoms may include nystagmus (involuntary eye movements), hypotonia, and ataxia (balance and coordination problems) [9]. As the condition progresses, individuals may experience muscle spasticity, weakness, and loss of ambulation.
Other clinical features associated with SCA8 include:
- Bulbous nose
- Dental crowding
- Gingival overgrowth
- High palate
- Long face
- Partial congenital absence of teeth [2]
- Hypometric saccades (abnormal eye movements)
- Limited mobility and weakness in the limbs
SCA8 is a rare condition, and its exact prevalence is unknown. However, it is considered to be one of the most common forms of autosomal dominant spinocerebellar ataxia.
References:
[1] Context 4 [2] Context 2 [3] Not applicable (no relevant information found) [4] Context 1 [5] Not applicable (no relevant information found) [6] Context 6 [7] Context 7 [8] Context 8 [9] Context 9
Additional Characteristics
- ataxia
- hyperreflexia
- nystagmus
- spasticity
- weakness
- hypotonia
- high palate
- bulbous nose
- loss of ambulation
- dental crowding
- gingival overgrowth
- long face
- partial congenital absence of teeth
- hypometric saccades
Signs and Symptoms
Signs and Symptoms of Spastic Ataxia
Spastic ataxia, also known as spinocerebellar ataxia (SCA), is a group of rare genetic disorders that affect the coordination and balance of the body. The signs and symptoms of spastic ataxia can vary depending on the specific type of SCA, but here are some common ones:
- Loss of coordination: People with spastic ataxia may experience difficulty walking, standing, or maintaining their balance.
- Slurred speech: Speech difficulties, including slurred or slow speech, are a common symptom of spastic ataxia.
- Trouble eating and swallowing: Some people with spastic ataxia may have trouble eating or swallowing due to muscle weakness or coordination problems.
- Deterioration of fine motor skills: Spastic ataxia can cause difficulties with fine motor tasks, such as writing, buttoning a shirt, or using small objects.
- Difficulty walking: Walking problems are a hallmark symptom of spastic ataxia, and may include stumbling, staggering, or having an unsteady gait.
- Gait abnormalities: People with spastic ataxia may have difficulty walking in a straight line, or may exhibit other unusual gait patterns.
- Eye symptoms: Some people with spastic ataxia may experience eye problems, such as nystagmus (abnormal eye movements) or vision loss.
These symptoms can vary in severity and may progress over time. If you're experiencing any of these symptoms, it's essential to consult a healthcare professional for proper diagnosis and treatment.
References:
- [8] Symptoms · Lack of coordination · Slurred speech · Trouble eating and swallowing · Deterioration of fine motor skills · Difficulty walking · Gait abnormalities · Eye problems.
Additional Symptoms
- Difficulty walking
- Gait abnormalities
- Trouble eating and swallowing
- Deterioration of fine motor skills
- Eye symptoms
- slurred speech
- obsolete loss of coordination
Diagnostic Tests
Diagnosing Spastic Ataxia 8 (SCA8)
Spastic ataxia 8 (SCA8) is a rare genetic disorder that affects the nervous system, causing progressive muscle weakness and coordination problems. Diagnosing SCA8 can be challenging, but several diagnostic tests are available to confirm the presence of this condition.
DNA-based Testing The most accurate way to diagnose SCA8 is through DNA-based testing, which can determine the presence or absence of the abnormal gene that causes the disorder [3]. This test involves analyzing a blood sample for the specific genetic mutation associated with SCA8.
Clinical Evaluation A thorough clinical evaluation by a neurologist or other healthcare professional is essential to diagnose SCA8. This includes:
- Medical history: Reviewing the patient's medical history, including symptoms and any previous diagnoses [10].
- Family history: Assessing the patient's family history for similar conditions or genetic disorders.
- Complete neurological evaluation: Conducting a comprehensive examination of the nervous system to identify signs of muscle weakness, coordination problems, and other symptoms associated with SCA8.
Other Diagnostic Tests While not as specific as DNA-based testing, other diagnostic tests may be used in conjunction with clinical evaluation to support a diagnosis of SCA8. These include:
- Brain imaging: Using techniques like MRI or CT scans to visualize the brain and identify signs of cerebellar atrophy and hypomyelinating leukodystrophy [6].
- Serological testing: Checking for paraneoplastic antibodies, which can indicate an underlying malignancy that may be causing rapid progression of ataxia [4].
Chromosomal Microarray Testing In some cases, chromosomal microarray testing may be used to diagnose the cause of ataxia, such as SCA15, which is often due to a copy number variant [9].
It's essential to note that diagnosing SCA8 can be complex and requires a comprehensive evaluation by a healthcare professional. If you suspect you or someone else may have this condition, consult with a neurologist or other qualified healthcare provider for proper diagnosis and care.
References:
[1] JD Cleary (2021) - [1] [3] [3] [4] RN de Silva (2019) - [4] [6] [6] [9] LJ Roberts (2022) - [9] [10] [10]
Additional Diagnostic Tests
- Clinical Evaluation
- Serological testing
- Brain imaging
- DNA-based Testing
- Chromosomal Microarray Testing
Treatment
Treatment Options for Spastic Ataxia
Spastic ataxia, also known as spinocerebellar ataxia (SCA), is a group of rare genetic disorders that affect the cerebellum and spinal cord. While there is no cure for SCA, various treatment options can help manage symptoms and improve quality of life.
Medications
One of the main treatment approaches for spastic ataxia is medication. The goal of medication is to alleviate symptoms such as muscle stiffness, spasms, and weakness. Some common medications used to treat SCA include:
- Anti-spasmodic oral medications: These medications can help reduce muscle stiffness and spasms. Examples include acetazolamide (see [7]) and other anti-epileptic drugs.
- Baclofen: This medication is often prescribed to manage muscle spasticity and stiffness.
Physical Therapy
In addition to medication, physical therapy plays a crucial role in managing SCA symptoms. Physical therapists can help patients maintain mobility, balance, and coordination by:
- Developing customized exercise programs
- Improving posture and gait
- Enhancing overall physical function
Other Therapies
Besides physical therapy, other therapies may be recommended to manage SCA symptoms. These include:
- Speech and language therapy: To address communication difficulties and swallowing problems.
- Occupational therapy: To help patients maintain independence in daily activities.
Citations: [8] - There is no cure for ARSACS. Treatment focuses on easing the symptoms and postponing major functional disabilities. Physical therapy and anti-spasmodic oral medications are common treatment options. [9] - Speech and language therapy, occupational therapy, and physical therapy are common treatment options. They are sometimes used in conjunction with medication to manage SCA symptoms. [7] - Acetazolamide remains the mainstay of treatment but carries a risk of renal calculi and (more commonly) of paraesthesia. As well as good hydration, we recommend anti-spasmodic oral medications like acetazolamide for managing SCA symptoms.
Recommended Medications
- anti-epileptic drugs
- acetazolamide
- Acetazolamide
- baclofen
- Baclofen
💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.
Differential Diagnosis
Differential Diagnosis of Spastic Ataxia
Spastic ataxia, a condition characterized by the combination of cerebellar ataxia with spasticity and other pyramidal features, has a rather limited differential diagnosis when considering the predominant clinical syndrome. However, as the list of causes of ataxia is extensive, it's essential to classify ataxia on the basis of whether it is sporadic or hereditary.
Hereditary Cerebellar Ataxias and Hereditary Spastic Paraplegias
Recognizing a spastic ataxia phenotype leads to a more restricted differential diagnosis. Hereditary cerebellar ataxias, such as autosomal dominant (AD) ataxias, autosomal recessive (AR) ataxias, and hereditary spastic paraplegias (SPG), are among the primary considerations in the differential diagnosis of spastic ataxia.
Other Clinical Differential Diagnoses
Other clinical differential diagnoses include Friedreich ataxia or POLG-associated ataxia. These conditions can present with similar symptoms to spastic ataxia, making accurate diagnosis crucial for appropriate management and treatment.
References:
- [1] Spastic ataxia is characterized by the combination of cerebellar ataxia with spasticity and other pyramidal features.
- [2] ... spastic-ataxia as the predominant clinical syndrome has a rather limited differential diagnosis.
- [4] Recognizing a spastic ataxia phenotype leads to a more restricted differential diagnosis.
- [5] Other clinical differential diagnoses include Friedreich ataxia or POLG-associated ataxia ...
- [6] Hereditary spastic ataxias comprise a very large differential diagnosis which includes AD ataxias, AR ataxias, and SPG with the combined ...
Additional Differential Diagnoses
- hypomyelinating leukodystrophy 8
- POLG-associated ataxia
- Hereditary cerebellar ataxias
- Hereditary spastic paraplegias (SPG)
- Friedreich ataxia 1
Additional Information
- rdf-schema#domain
- https://w3id.org/def/predibionto#has_symptom_2622
- owl#annotatedSource
- t353817
- oboInOwl#hasOBONamespace
- disease_ontology
- oboInOwl#id
- DOID:0080252
- core#notation
- DOID:0080252
- oboInOwl#hasDbXref
- MIM:617560
- IAO_0000115
- A spastic ataxia that is characterized by onset of primarily motor dysfunction within the first year of life and that has_material_basis_in homozygous mutation in the NKX6-2 gene on chromosome 8q21.
- rdf-schema#label
- spastic ataxia 8
- rdf-schema#subClassOf
- t353473
- IDO_0000664
- http://purl.obolibrary.org/obo/GENO_0000148
- 22-rdf-syntax-ns#type
- http://www.w3.org/2002/07/owl#Class
Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.
It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.